Semler Scientific Class Action Filed Over Alleged Securities Fraud.
PorAinvest
sábado, 6 de septiembre de 2025, 10:32 am ET1 min de lectura
SMLR--
The lawsuit, initially filed by The Rosen Law Firm, alleges that Semler Scientific did not disclose a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act. This failure to disclose led to investors suffering damages when the true details emerged [2].
Semler Scientific's stock price has been significantly impacted by these revelations. On February 28, 2025, the company disclosed the DOJ investigation, leading to a $4.03 drop in stock price, or a 9.4% decrease. On April 15, 2025, Semler announced a settlement with the DOJ for $29.75 million, resulting in a further $3.40 drop in stock price, a 9.9% decrease [1].
Investors who purchased Semler securities during the Class Period have until October 28, 2025, to seek appointment as Lead Plaintiff in the lawsuit. This deadline is crucial as it allows investors to direct the litigation and potentially recover damages [1].
To participate or learn more about the class action, investors can contact Glancy Prongay & Murray LLP at 310-201-9150 or shareholders@glancylaw.com, or The Rosen Law Firm at 866-767-3653 or case@rosenlegal.com [1][2].
References:
[1] https://www.morningstar.com/news/business-wire/20250905390183/deadline-alert-semler-scientific-inc-smlr-investors-who-lost-money-urged-to-contact-glancy-prongay-murray-llp-about-securities-fraud-lawsuit
[2] https://www.morningstar.com/news/pr-newswire/20250903dc64768/smlr-investors-have-opportunity-to-lead-semler-scientific-inc-securities-fraud-lawsuit-first-filed-by-the-rosen-law-firm
A class action lawsuit has been filed against Semler Scientific, Inc. (NASDAQ: SMLR) alleging securities fraud and unlawful business practices. Investors who purchased Semler securities during the Class Period have until October 28, 2025 to seek appointment as Lead Plaintiff. The lawsuit concerns whether Semler and certain officers/directors engaged in fraudulent practices.
Semler Scientific, Inc. (NASDAQ: SMLR) is facing a class action lawsuit alleging securities fraud and unlawful business practices. The lawsuit, filed on behalf of investors who purchased Semler securities between March 10, 2021, and April 15, 2025, claims that the company made materially false and misleading statements and failed to disclose significant adverse facts about its business and operations.The lawsuit, initially filed by The Rosen Law Firm, alleges that Semler Scientific did not disclose a material investigation by the United States Department of Justice (DOJ) into violations of the False Claims Act. This failure to disclose led to investors suffering damages when the true details emerged [2].
Semler Scientific's stock price has been significantly impacted by these revelations. On February 28, 2025, the company disclosed the DOJ investigation, leading to a $4.03 drop in stock price, or a 9.4% decrease. On April 15, 2025, Semler announced a settlement with the DOJ for $29.75 million, resulting in a further $3.40 drop in stock price, a 9.9% decrease [1].
Investors who purchased Semler securities during the Class Period have until October 28, 2025, to seek appointment as Lead Plaintiff in the lawsuit. This deadline is crucial as it allows investors to direct the litigation and potentially recover damages [1].
To participate or learn more about the class action, investors can contact Glancy Prongay & Murray LLP at 310-201-9150 or shareholders@glancylaw.com, or The Rosen Law Firm at 866-767-3653 or case@rosenlegal.com [1][2].
References:
[1] https://www.morningstar.com/news/business-wire/20250905390183/deadline-alert-semler-scientific-inc-smlr-investors-who-lost-money-urged-to-contact-glancy-prongay-murray-llp-about-securities-fraud-lawsuit
[2] https://www.morningstar.com/news/pr-newswire/20250903dc64768/smlr-investors-have-opportunity-to-lead-semler-scientific-inc-securities-fraud-lawsuit-first-filed-by-the-rosen-law-firm
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios